Genome-wide molecular characterization of mucinous colorectal adenocarcinoma using cDNA microarray analysis

Oncology Reports

Volumn 25, Issue 3, 2011, Pages 717-727

  Kim, Han Sang ^a   Kang, Seung Hui ^a   Park, Chan Hee ^a   Yang, Woo Ick ^b   Jeung, Hei Cheul ^a   Chung, Hyun Cheol ^a   Roh, Jae Kyung ^a   Ahn, Joong Bae ^a   Kim, Nam Kyu ^b   Min, Byung Soh ^b   Rha, Sun Young ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

cDNA microarray; Classification analysis; Colorectal cancer; In silico analysis; Mucinous carcinoma

Indexed keywords

COMPLEMENTARY DNA;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CARBOHYDRATE METABOLISM; CARCINOGENESIS; CELL ADHESION; CELL CYCLE PROGRESSION; CELL PROLIFERATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENOME; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUCINOUS CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION PROCESS;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; VALIDATION STUDIES AS TOPIC;

EID: 79551613285     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2010.1126     Document Type: Article

References (27)

1. Adell R, Marcote E, Segarra MA, Pellicer V, Gamon R, Bayon AM, Canales M and Torner A: Is mucinous colorectal adenocarcinoma a distinct entity? Gastroenterol Hepatol 25: 534-540, 2002.
2. Okuno M, Ikehara T, Nagayama M, Kato Y, Yui S and Umeyama K: Mucinous colorectal carcinoma: clinical pathology and prognosis. Am Surg 54: 681-685, 1988.
3. Nozoe T, Anai H, Nasu S and Sugimachi K: Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol 75: 103-107, 2000.
4. Consorti F, Lorenzotti A, Midiri G and Di Paola M: Prognostic significance of mucinous carcinoma of colon and rectum: a prospective case-control study. J Surg Oncol 73: 70-74, 2000.
5. Secco GB, Fardelli R, Campora E, Lapertosa G, Gentile R, Zoli S and Prior C: Primary mucinous adenocarcinomas and signetring cell carcinomas of colon and rectum. Oncology 51: 30-34, 1994.
6. Arai T, Kasahara I, Sawabe M, Kanazawa N, Kuroiwa K, Honma N, Aida J and Takubo K: Microsatellite-unstable mucinous colorectal carcinoma occurring in the elderly: comparison with medullary type poorly differentiated adenocarcinoma. Pathol Int 57: 205-212, 2007.
7. Kondo T, Masuda H, Abe Y and Takayama T: Two subtypes in colorectal mucinous carcinoma in relation to microsatellite instability. Hepatogastroenterology 49: 660-663, 2002.
8. Ogino S, Brahmandam M, Cantor M, Namgyal C, Kawasaki T, Kirkner G, Meyerhardt JA, Loda M and Fuchs CS: Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component. Mod Pathol 19: 59-68, 2006.
9. Tanaka H, Deng G, Matsuzaki K, Kakar S, Kim GE, Miura S, Sleisenger MH and Kim YS: BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non-mucinous colorectal cancer. Int J Cancer 118: 2765-2771, 2006.
10. Yoshitake N, Fujii S, Mukawa K, Tominaga K, Fukui H, Ichikawa K, Tomita S, Ono Y, Imai Y, Terano A, Hiraishi H and Fujimori T: Mutational analysis of the BRAF gene in colorectal mucinous carcinoma in association with histological configuration. Oncol Rep 17: 9-15, 2007.
11. Ishizu H, Kumagai J, Eishi Y, Takizawa T and Koike M: Mucin core protein expression by colorectal mucinous carcinomas with or without mucus hyperplasia. J Gastroenterol 39: 125-132, 2004.
12. Kim DH, Kim JW, Cho JH, Baek SH, Kakar S, Kim GE, Sleisenger MH and Kim YS: Expression of mucin core proteins, trefoil factors, APC and p21 in subsets of colorectal polyps and cancers suggests a distinct pathway of pathogenesis of mucinous carcinoma of the colorectum. Int J Oncol 27: 957-964, 2005.
13. Clarke PA, te Poele R, Wooster R and Workman P: Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential. Biochem Pharmacol 62: 1311-1136, 2001.
14. Wong YF, Selvanayagam ZE, Wei N, Porter J, Vittal R, Hu R, Lin Y, Liao J, Shih JW, Cheung TH, Lo KW, Yim SF, Yip SK, Ngong DT, Siu N, Chan LK, Chan CS, Kong T, Kutlina E, McKinnon RD, Denhardt DT, Chin KV and Chung TK: Expression genomics of cervical cancer: molecular classification and prediction of radiotherapy response by DNA microarray. Clin Cancer Res 9: 5486-5492, 2003.
15. Kim TM, Jeong HJ, Seo MY, Kim SC, Cho G, Park CH, Kim TS, Park KH, Chung HC and Rha SY: Determination of genes related to gastrointestinal tract origin cancer cells using a cDNA microarray. Clin Cancer Res 11: 79-86, 2005.
16. Samowitz WS, Sweeney C, Herrick J, Albertsen H, Levin TR, Murtaugh MA, Wolff RK and Slattery ML: Poor survival associated with the BRAF V600E mutation in microsatellitestable colon cancers. Cancer Res 65: 6063-6069, 2005.
17. Antalis TM, Reeder JA, Gotley DC, Byeon MK, Walsh MD, Henderson KW, Papas TS and Schweinfest CW: Downregulation of the down-regulated in adenoma (DRA) gene correlates with colon tumor progression. Clin Cancer Res 4: 1857-1863, 1998.
18. Byeon MK, Westerman MA, Maroulakou IG, Henderson KW, Suster S, Zhang XK, Papas TS, Vesely J, Willingham MC, Green JE and Schweinfest CW: The down-regulated in adenoma (DRA) gene encodes an intestine-specific membrane glycoprotein. Oncogene 12: 387-396, 1996.
19. Schweinfest CW, Henderson KW, Suster S, Kondoh N and Papas TS: Identification of a colon mucosa gene that is down-regulated in colon adenomas and adenocarcinomas. Proc Natl Acad Sci USA 90: 4166-4170, 1993.
20. Chapman JM, Knoepp SM, Byeon MK, Henderson KW and Schweinfest CW: The colon anion transporter, down-regulated in adenoma, induces growth suppression that is abrogated by E1A. Cancer Res 62: 5083-5088, 2002.
21. Jawhari AU, Buda A, Jenkins M, Shehzad K, Sarraf C, Noda M, Farthing MJ, Pignatelli M and Adams JC: Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am J Pathol 162: 69-80, 2003.
22. Yoder BJ, Tso E, Skacel M, Pettay J, Tarr S, Budd T, Tubbs RR, Adams JC and Hicks DG: The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course. Clin Cancer Res 11: 186-192, 2005.
23. Bates RC, Edwards NS, Burns GF and Fisher DE: A CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells. Cancer Res 61: 5275-5283, 2001.
24. Fujisaki T, Tanaka Y, Fujii K, Mine S, Saito K, Yamada S, Yamashita U, Irimura T and Eto S: CD44 stimulation induces integrin-mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins. Cancer Res 59: 4427-4434, 1999.
25. Bossenmeyer-Pourie C, Kannan R, Ribieras S, Wendling C, Stoll I, Thim L, Tomasetto C and Rio MC: The trefoil factor 1 participates in gastrointestinal cell differentiation by delaying G1-S phase transition and reducing apoptosis. J Cell Biol 157: 761-770, 2002.
26. Emami S, Le Floch N, Bruyneel E, Thim L, May F, Westley B, Rio M, Mareel M and Gespach C: Induction of scattering and cellular invasion by trefoil peptides in src- and RhoA-transformed kidney and colonic epithelial cells. FASEB J 15: 351-361, 2001.
27. Rodrigues S, Nguyen QD, Faivre S, Bruyneel E, Thim L, Westley B, May F, Flatau G, Mareel M, Gespach C and Emami S: Activation of cellular invasion by trefoil peptides and src is mediated by cyclooxygenase- and thromboxane A2 receptor-dependent signaling pathways. FASEB J 15: 1517-1528, 2001.